Document is current

Article History

Received: 1 February 2026

Accepted: 4 May 2026

First Online: 24 May 2026

Declarations

:

: The authors declare no competing interests.

: The research protocol received approval from the Research Ethics Committee at the Kerman University of Medical Sciences (ID number: IR.KMU.REC.1402.304). and all patients and controls signed an informed consent document in accordance with the statement of Helsinki.

: Informed consent was obtained from all individual participants included in the study in compliance with the Declaration of Helsinki. In order to publish this manuscript, written informed consent has been obtained from all study subjects.

: All laboratory procedures involving human blood samples were conducted in a BSL-2 (Biosafety Level 2) facility, adhering to standard biosafety protocols to ensure the safety of personnel and the environment. The research utilized only human-derived RNA and did not involve the manipulation of pathogenic microorganisms or toxins. Therefore, this study did not raise significant biosecurity concerns as defined by international dual-use research of concern guidelines.